29 September 2025 ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update read more
22 September 2025 The Endpoints 11: At Third Arc, a small team with major league talent tackles some big disease targets read more
11 September 2025 LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering read more
30 June 2025 AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology read more
